John Barter Appointed to Engility Board of Directors

CHANTILLY, Va.--(BUSINESS WIRE)-- Engility Holdings, Inc. (NYSE: EGL) today announced that John Barter has been appointed to the company’s Board of Directors. The appointment increases the number of Engility directors to 10 members.

“John brings a wealth of industry knowledge, financial expertise, and a track record of strategic leadership to the Engility board,” said Lynn Dugle, Engility CEO. “We look forward to working with John as we continue to deliver innovative solutions to our customers, execute on our growth strategy, and bring value to our stakeholders.”

Barter’s distinguished career included 20 years at AlliedSignal, now part of Honeywell, where he held leadership roles, including the company’s chief financial officer and chief executive officer for the $6 billion automotive division.

Barter currently serves on the Board of Directors for DHI Group, QTS Realty Trust, and the Medical University of South Carolina Foundation.

About Engility

Engility (NYSE: EGL) is engineered to make a difference. Built on five decades of heritage, Engility is a leading provider of integrated solutions and services for the U.S. government, supporting customers throughout defense, intelligence, space, federal civilian and international communities. Engility delivers world-class performance, efficiency and best value in a broad range of services from global security to information security, and from international development to research and development. Headquartered in Chantilly, Virginia, and with offices around the world, Engility draws upon its intimate understanding of customer needs, deep domain expertise, and skilled team to develop and deliver on-target solutions for critical missions. To learn more about Engility, please visit www.engilitycorp.com and connect with us on Facebook, LinkedIn and Twitter.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170103005073/en/

Engility Holdings Inc.
Corporate Communications
Roela Santos
703-984-6246
[email protected]
or
Engility Holdings Inc.
Investor Relations
Dave Spille
703-984-6120
[email protected]

Source: Engility Holdings, Inc.

You May Also Be Interested In

• Beazer Homes closes $400M senior notes offering due 2032
• FDA backs Entera Bio's Phase 3 trial plan for oral osteoporosis drug
• FDA grants breakthrough therapy status to Praxis drug for rare epilepsy